Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Tenax Therapeutics, Inc. | StockGist | StockGist

Companies
TENX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings TENXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Tenax Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0000034956

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

6,243,575

Reporting Person

TENAX THERAPEUTICS, INC.

Person Type

PN

CUSIP: 88032L605

Amendment History

8 filings

SCHEDULE 13G
Original
Feb 12, 20260000895421-26-000063
SCHEDULE 13G/A
Amendment 1
Feb 17, 20260000929638-26-000667
SCHEDULE 13G/A
Amendment 2
Feb 17, 20260001738048-26-000032
SCHEDULE 13G/A
Amendment 3
Feb 17, 20260001193125-26-054537
SCHEDULE 13G/A
Amendment 4
Viewing
Feb 17, 20260001943462-26-000004
SCHEDULE 13G/A
Amendment 5
Feb 17, 20260000921895-26-000474
SCHEDULE 13G/A
Amendment 6
Feb 17, 20260001493215-26-000052
SCHEDULE 13G/A
Amendment 7
Latest
Feb 17, 20260000902664-26-001129

Key Facts

Shares Owned

6,243,575

Recent Filings

Tenax Therapeutics, Inc.3 weeks ago

Tenax Therapeutics, Inc.3 weeks ago

Tenax Therapeutics, Inc.1 months ago

Tenax Therapeutics, Inc.1 months ago

Tenax Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice